A new experimental Alzheimer’s compound called FLAV-27 improved memory and reduced disease-like damage in worms and mice.

A novel approach using a lysosomal enzyme to prevent and reverse amyloid accumulation inside as well as outside neurons, with greater potency, ...

Unlike conventional Alzheimer's drugs that largely manage memory loss and behavioural symptoms, donanemab targets ...

Scientists have discovered a way to help the brain clean itself of harmful Alzheimer’s plaques by activating its own support cells. By increasing a protein called Sox9, researchers were able to boost ...

Scientists in Japan found that arginine, a common amino acid already used in supplements and medicine, reduced harmful ...

Add Yahoo as a preferred source to see more of our stories on Google. An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to ...

The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...

A major review challenges a long-standing strategy in Alzheimer’s research, suggesting that removing a hallmark brain protein may not lead to meaningful improvements for patients.

Dopamine could potentially treat Alzheimer’s by stimulating the production of an enzyme that breaks down beta-amyloid plaques, researchers say. Qi Yang/Getty ImagesThis article originally appeared on ...

How exactly do amyloid plaques affect surrounding brain tissue, and does this change over time? Scientists led by Jörg Hanrieder at the University of Gothenburg, Sweden, tackled this question by using ...

A new kind of cellular immunotherapy shows promise in preventing Alzheimer's-associated plaques from forming in the brain – and even removing some when given in advanced cases. Working with mice, ...

An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to form plaques that collect between neurons and disrupt cell function. - ...